Please provide your email address to receive an email when new articles are posted on . The rate of exacerbation was 46.8% in the group using metformin and 63% in the group not using metformin. The ...
Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk ...
Table 1 reports the total number of patients with COPD and the number experiencing an MI or stroke. There were 25,857 patients with COPD in 277 practices at the start of the observation period. Over ...
The SPIROMICS study found considerable year-to-year heterogeneity in acute chronic obstructive pulmonary disease (COPD) exacerbation patterns over 3 years of follow-up. Similarly, a Danish nationwide ...
To derive a clinical prediction rule (CPR) for short-term death following an acute exacerbation of COPD (AECOPD). All persons ⩾40 years (to exclude patients with potential asthma) attending a HC of ...
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease affecting at least 15 million American adults. It’s also the fourth leading cause of disease-attributed death. This makes ...
A recent study explored exacerbation history to determine what it revealed about prognosis. The findings suggested that exacerbation severity history was predictive of future exacerbation status.
Getting an asthma diagnosis means you have to learn some new lingo. Your doctor may throw around phrases like “peak flow readings” (a way to measure how well your lungs are functioning), “short-acting ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Mepolizumab reduced the risk for a first severe ...
Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...
The HALP score as a prognostic biomarker in non-small cell lung cancer: A comprehensive meta-analysis of over 7,000 patients. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...